Professor

Faculty Details

  • Citations 926
  • HIndex 16
  • i10 Index 23
  • Mobile 9469042001
  • Email rashid.fouzia@gmail.com
  • Administrative position Held HEAD, CO-ORDINATOR, ACADEMIC COUNSELLOR
  • Resume View



Research Papers Published

  • "DNA repair gene XRCC1 in relation to genome instability and role in colorectal carcinogenesis." Oncology research & Treatment., 37(78): 418 -422 {ISSN: 10.1159} Impact Factor= 1.5
  • "High sensitivity hs-CRP levels and its relationship with PCOS in Indian Adolescent women with PCOS." Gynecological Endocrinology, 19(19): 1 -4 {ISSN: 12267} Impact Factor= 1.136
  • "Polymorphism of the DNA Repair Gene XRCC1 (Arg194Trp) and its role in Colorectal Cancer in Kashmiri Population: a Case Control Study" Asian Pacific Journal of Cancer Prevention, 16(15): 6385 -6390 {ISSN: 10.7314} Impact Factor= 2.514
  • "Does the Oral Contraceptive Pill Increase Plasma Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1, and Tumor Necrosis Factor-a Levels in Women with Polycystic Ovary Syndrome: A Pilot Study." J Pediatr Adolesc Gynecol., 7(2): 1 -7 {ISSN: 1083-3188} Impact Factor= 1.683
  • "The ICAM-1 Gly241Arg Polymorphism is Not Associated With Polycystic Ovary Syndrome - Results from a Case Control study in Kashmir, India." Asian Pac J Cancer Prev., 17(3): 1583 -1591 {ISSN: 1513-7368} Impact Factor= 2.514
  • "Role of TLR4 gene polymorphisms in the colorectal cancer risk modulation in ethnic Kashmiri population – A case–control study" Egyptian Journal of Medical Human Genetics, 10(5): 1 -7 {ISSN: 1110-8630} Impact Factor= 0.404
  • "Does the Oral Contraceptive Pill Increase Plasma Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1, and Tumor Necrosis Factor-a Levels in Women with Polycystic Ovary Syndrome: A Pilot Study" J Paed Adol & Gynecology, 10(1): 58 -62 {ISSN: 1083-3188} Impact Factor= 1.9
  • "The ICAM-1 Gly241Arg Polymorphism is Not Associated With Polycystic Ovary Syndrome - Results from a Case Control study in Kashmir, India." Asian Paci J of cancer prevention, 17(3): 153 -158 {ISSN: 1513-7368} Impact Factor= 2.6
  • "Glutathione S Transferases: Biochemistry, Polymorphism and Role in Colorectal Carcinogenesis" Journal of Carcinogenesis & Mutagenesis, 8(2): 1 -9 {ISSN: 2157-2518} Impact Factor= 2.5
  • "Evaluation of deletion polymorphisms of glutathione S-transferase genes and colorectal cancer risk in ethnic Kashmiri population: A case-control study" Indian J Cancer, 53(4): 524 -528 {ISSN: 1998-4774} Impact Factor= 0.497
  • "Metabolic Derangements and Possible CVD Risk in PCOS Women Owing to Use of OCP’s as a Treatment Mode – Pros and Cons." Journal of Endocrinology, Diabetes & Obesity, 5(3): 1109 -1119 {ISSN: 2333-6692} Impact Factor= 0.3
  • "Comparative analysis of the Clinical, biochemical and hormonal profile of obese versus lean kashmiri PCOS patients-A pilot study" International journal of Advances in Science Engineering and Technology., 5(2): 65 -70 {ISSN: 2321-9009} Impact Factor= 2.5
  • "Does the Oral Contraceptive Pill Increase Plasma Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1, and Tumor Necrosis Factor-a levels in Women with Polycystic Ovary Syndrome: A Pilot Study." J Pediatr Adolesc Gynecol, 30:58-62(1): 58 -62 {ISSN: 1083-3188} Impact Factor= 1.683
  • "POLYCYSTIC OVARY SYNDROME (PCOS) AND RELATED DISEASES" PRECISION MEDICINE, 2(1): 23 -29 {ISSN: 2456-2254} Impact Factor= 0.1
  • "OXIDATIVE STRESS BIOMARKERS IN POLYCYSTIC OVARY SYNDROME (PCOS)" PRECISION MEDICINE, 2(1): 30 -38 {ISSN: 2456-2254} Impact Factor= 0.1
  • "Effect of six-month use of oral contraceptive pills on plasminogen activator inhibitor-1 & factor VIII among women with polycystic ovary syndrome: An observational pilot study" IJMR, 2019(148): 151 -155 {ISSN: IP: 125.19} Impact Factor= 1.59
  • "Effect of Paraoxonase1 (PON1) gene polymorphisms on PON1 activity, HDL, LDL and MDA levels in women with polycystic ovary syndrome (PCOS): A case-control study" META GENE, 2019(20): 100052 -100053 {ISSN: 2214-5400} Impact Factor= 0.89
  • "Evaluation of antioxidant defense markers in relation to hormonal and insulin parameters in women with polycystic ovary syndrome (PCOS): A case-control study." Diabetes & Metabolic Syndrome: Clinical Research & Reviews., 2019(13): 1957 -61 {ISSN: 1871-4021} Impact Factor= 0.84
  • "Evaluation of prescription pattern and compliance in Kashmiri women with Polycystic Ovarian Syndrome." Journal of Drug Delivery and Therapeutics., 2019(9(3)): 379 -383 Impact Factor=
  • "Bisphenol A (BPA) acts as an endocrine disruptor in women with Polycystic Ovary Syndrome: Hormonal and metabolic evaluation." Obesity Medicine, 2019(14): 2451 -2476 Impact Factor=
  • "Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome" Diabetes & metabolic syndrome: Clinical Research & Reviews, 2019(13(3)): 2098 -2105 Impact Factor=
  • "Insulin gene VNTR class III allele is a risk factor for insulin resistance in Kashmiri women with polycystic ovary syndrome" Meta Gene., 2019(100597): 100597 -100606 Impact Factor=
  • "Assessment of PON1 activity and circulating TF levels in relation to BMI, testosterone, HOMA-IR, HDL-C, LDL-C, CHO, SOD activity and TAC in women with PCOS: An observational study." Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2019(12): 1871 -1878 Impact Factor=
  • "Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: An observational study" Scientific reports, 2019(9): 10182 -10187 Impact Factor=
  • "CYP 17 gene polymorphic sequence variation is associated with hyperandrogenism in Kashmiri women with polycystic ovarian syndrome." Gynecological Endocrinology, 2(2): 1 -6 {ISSN: 0951-3590} Impact Factor= 2.1
  • "AT-rich Interaction domain 1A Gene variations: Genetic associations and susceptibility to gastric cancer." Pathology and oncology Research, 2(2): 1 -6 {ISSN: 1532-2807} Impact Factor= 2.8
  • "Analysis of Intrinsic and Extrinsic Coagulation Pathway Factors in OCP Treated PCOS Women." Indian j Clinical Biochemistry, 1(2): 1 -12 {ISSN: 0974-04 22} Impact Factor= 1.4
  • "Association of Paraoxonase1 enzyme and its genetic single nucleotide polymorphisms with cardio-metabolic and neurodegenerative diseases." Gene Reports, 1(2): 1 -9 {ISSN: 2452-01 44} Impact Factor= 0.9
  • "Endocrine disrupting chemical Bisphenol A and its potential effects on female health." Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 1(2): 1 -10 {ISSN: 11} Impact Factor= 1.8
  • "HIGH PREVALENCE OF METABOLIC SYNDROME IN KASHMIR (INDIA) ADULT POPULATION: TIME TO INTERVENE." Archives of Medicine and Health Sciences, 5(4): 1 -8 {ISSN: 2141-9248} Impact Factor= 0.9
  • "Implication of ARID1A Undercurrents and PDL1, TP53 Overexpression in Advanced Gastric Cancer." Pathology and Oncology Research, 27(1): 1609826 -1609830 {ISSN: 1219-4956} Impact Factor= 3.201
  • "Association of -675 4G/5G PAI-1 and -2518A/G MCP-1 genetic polymorphisms with polycystic ovary syndrome in Kashmiri women: A case control study." Journal of Family Medicine and Primary Care | Published by Wolters Kluwer - Medknow, 11(2022;11:): 4743 -4752 {ISSN: 2249-4863} Impact Factor= 0.62
  • "Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-a (TNF-a), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1(PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women." BMC WOMEN;S HEALTH, 23(23): 68 -75 {ISSN: 1472-6874} Impact Factor= 3.25

Books Published

  • "Proteostasis and Chaperone Surveillance/ Protein Misfolding diseases: In perspective of Gain and Loss of function". Springer , India. {ISBN: 978-81-322-2466-2} pp 14
  • "Microbes in Reproductive tract spectrum: Inferences from microbial world. ( Pathogenicity and drug resistance of Human pathogens).". Springer International. {ISBN: 978-981-329-449-3} pp 14
  • "An Overview of Possible Health Risk and Complications of Polycistic Ovary Syndrome.". Categories: 2021, Books, Endocrinology, Endocrinology Research and Clinical Developments, Medicine & Health, Medicine and Health, Newly Published Books, Nova Medicine and Health. {ISBN: ISBN: 978-1-53619-527-9} pp 179
  • "Polycystic Ovary Syndrome: A Fresh Insight in Relation to Its Inflammatory and Coagulatory Pathophysiology.". Categories: 2021, Books, Endocrinology, Endocrinology Research and Clinical Developments, Medicine & Health, Medicine and Health, Newly Published Books, Nova Medicine and Health. {ISBN: ISBN: 978-1-53619-527-9} pp 179
  • "Tissue Factor and Human Pathologies: A Comprehensive Insight.". Advances in Health and Disease. Volume 50. Nova Medicine and Health. {ISBN: 978-1-68507-564-4} pp 25
  • "TISSUE FACTOR AND HUMAN PATHOLOGIES: A COMPREHENSIVE INSIGHT/ Avances in Health and Disease Humira Jeelani1, Muzamil Farooq2, Fasil Ali3, and Fouzia Rashid1,". Nova Publishers USA. {ISBN: TISSUE FACTOR AND HUMAN PATHO} pp 30
  • "8. Thrombophilia and Its Markers: A Comprehensive Insight". SPRINGER. {ISBN: 978-981-99-2192-8} pp 15
  • "9. Polycystic Ovary Syndrome (PCOS): Clinical Features, Risk Factors, Biomarkers, Treatment, and Therapeutic Strategies". SPRINGER. {ISBN: 978-981-99-2192-8} pp 16

Research Projects Details:

Title of the ProjectFunding AgencyDatedAmount (in Rs.)
Metabolic Evaluation Of Oral Contraceptive (OCP’s) Treated Polycystic Ovary Syndrome (PCOS) WomenUGC31-03-20150.00
Quantitation and Comparative Evaluation of Insulin resistance, Proinflammatory and Procoagulant Markers in Drug Naive versus Oral Contraceptive Pills (OCP’S) Treated PCOS WomenJKDST29-01-201818.00
3. Evaluation of genetic variants of ICAM-1, TNF-a, MCP-1, and PAI-1 gene in Kashmiri polycystic ovary syndrome (PCOS) women and Comparative expression analysis of these genes in drug naive versus oral contraceptive pills (OCP’s) treated PCOS womenDST-WOSA31-03-20182,200,000.00
1. High altitude induced thrombosis in transhumant pastoralist Gujjar-Bakarwal population of Jammu and Kashmir: A prospective, longitudinal observational studyDHR/ICMR04-08-20024,648,944.00

Research Scholars:

NameCourseStatusNature
SAIKA MANZOORM.Phil Awarded Whole Time
QUDSIYA FATIMAM.Phil Awarded Whole Time
IRAM ASHIQPh.D Awarded Whole Time
SAKINA MUSTAFAPh.D Awarded Whole Time
syed douhathPh.D Awarded Whole Time
Humira JeelaniPh.D Awarded Whole Time
humira jeelaniPh.D Awarded Whole Time
Insha DinPh.D Awarded Whole Time
SAIKA MANZOORPh.D Awarded Whole Time

Teaching:

DepartmentSubjectCourse TaughtSemester
Clinical Bio-ChemistryMSc. Clinical BiochemistryBiomolecules II1
Clinical Bio-ChemistryMSc. Clinical BiochemistryBasic concepts in clinical biochemistry1
Clinical Bio-ChemistryMSc. Clinical BiochemistryMOLECULAR BIOLOGY2
Clinical Bio-ChemistryMSc. Clinical BiochemistryPHARMACOLOGY3
Clinical Bio-ChemistryMSc. Clinical BiochemistryACID BASE DISORDERS3
Clinical Bio-ChemistryMSc. in Clinical BiochemistryLab course III3
Clinical Bio-ChemistryMSc. in Clinical BiochemistryCardiovascular system and diseases3
Clinical Bio-ChemistryPhD. in Clinical BiochemistryLife style diseases5